NIAID Awards $14M for Institutional Review Services to Advarra
The National Institutes of Health (NIH) has chosen Advarra as its exclusive single institutional review board (sIRB) for clinical...
Unlock the Secrets of Parkinson’s: Cambridge Cognition and Fox Foundation Team Up
Cambridge Cognition, a leader in digital brain health assessment solutions, and The Michael J. Fox Foundation for Parkinson’s Disease...
Remepy Unveils $15 Million Investment for Revolutionary Drug
Remepy, a pioneer in “hybrid drugs,” has secured $15 million in funding, led by NFX and supported by several...
Ultrasound Therapy Shows Promise in Relieving Rheumatoid Arthritis
SecondWave Systems has made a breakthrough in the treatment of rheumatoid arthritisarthritis (RA) with their novel ultrasonic stimulation technology....
Unlocking New Clinical Trial Digital Health Advances
In an insightful discussion, Tom White, Chief Product Officer of Nye Health, highlights the company’s innovations in clinical trial...
Innovative Tech Solutions for Challenges in Clinical Research
In this insightful session about challenges in clinical research, I spoke with Aruna Adhikari, Head of Product and Senior...
Liberate Medical Breakthrough: $6.5m Grant Enrolls Patients in Global Study
The PREVENT trial is a groundbreaking clinical study investigating the VentFree Respiratory Muscle Stimulator’s efficacy in reducing the duration...
Molecular Farming: Surging Global Market to 2028, Fueled by Pharmaceutical Demand
The global molecular farming market is poised to witness significant growth, expanding from $454.1 million in 2023 to a...
Akili Shifts Strategy, Delays Earnings Amid Partner Amendment
Akili, Inc. announced several corporate developments, including an amendment to its partnership with Shionogi & Co. The amended agreement...
Qlaris Bio Secures $24 Million Funding for Revolutionary Glaucoma Drug Development
Qlaris Bio, a biotechnology company specializing in ophthalmic diseases, secured $24 million in Series B financing. The round was...